MIRA (MIRA Pharmaceuticals, Inc. Common Stock) Stock Analysis - SEC Filings
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a publicly traded Healthcare sector company. As of May 21, 2026, MIRA trades at $1.00 with a market cap of $41.01M and a P/E ratio of -0.72. MIRA moved +0.00% today. Year to date, MIRA is -35.06%; over the trailing twelve months it is -26.14%. Its 52-week range spans $0.73 to $2.56. Rallies surfaces MIRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Where can I find MIRA SEC filings?
Rallies organizes MIRA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Aminov Erez sold 613.60K (~$1.29M) on Oct 16, 2025.
Aminov Erez sold 44.59K (~$56.63K) on Nov 20, 2024.
Aminov Erez sold 55.41K (~$77.02K) on Nov 19, 2024.
MIRA Analyst Consensus
MIRA analyst coverage data. Average price target: $0.00.
Common questions about MIRA
Where can I find MIRA SEC filings?
Rallies organizes MIRA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show MIRA 10-K and 10-Q filings?
Rallies organizes MIRA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is MIRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MIRA. It does not provide personalized investment advice.